Strasbourg, France · Founded 2017 · Privately Held (backing)
Developer of a peptide-based drug designed to offer treatment for patients suffering from type 2 diabetes. AdipoPharma is based in Strasbourg, France and was founded in 2017. Its last known valuation is $18.4 million. It has raised $34.5 million.
Last price · $/share
—
Implied valuation
$18.4M
Total raised
$34.5M
Last round
—
Team — not yet on record
No current team members for AdipoPharma are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of AdipoPharma with a free account
·The complete investor list: 11 names
·Watch AdipoPharma: the Monday email on marks, rounds and moves
